Transarterial chemoembolization with miriplatin vs. epirubicin for unresectable hepatocellular carcinoma: a phase III randomized trial

[1]  M. Kudo,et al.  General Rules for the Clinical and Pathological Study of Primary Liver Cancer, Nationwide Follow-Up Survey and Clinical Practice Guidelines: The Outstanding Achievements of the Liver Cancer Study Group of Japan , 2015, Digestive Diseases.

[2]  Sang Joon Park,et al.  Prospective study of transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: an Asian cooperative study between Japan and Korea. , 2013, Journal of vascular and interventional radiology : JVIR.

[3]  K. Takayasu.  Transarterial chemoembolization for hepatocellular carcinoma over three decades: current progress and perspective. , 2012, Japanese journal of clinical oncology.

[4]  M. Yoshikawa,et al.  A randomized phase II trial of intra-arterial chemotherapy using SM-11355 (Miriplatin) for hepatocellular carcinoma , 2011, Investigational New Drugs.

[5]  M. Makuuchi,et al.  Management of Hepatocellular Carcinoma in Japan: Consensus-Based Clinical Practice Guidelines Proposed by the Japan Society of Hepatology (JSH) 2010 Updated Version , 2011, Digestive Diseases.

[6]  M. Ikeda,et al.  [Transcatheter arterial chemoembolization with a lipophilic platinum complex SM-11355(miriplatin hydrate)--safety and efficacy in combination with embolizing agents]. , 2010, Gan to kagaku ryoho. Cancer & chemotherapy.

[7]  日本肝癌研究会.  General rules for the clinical and pathological study of primary liver cancer , 2010 .

[8]  M. Kudo,et al.  Transarterial chemotherapy alone versus transarterial chemoembolization for hepatocellular carcinoma: a randomized phase III trial. , 2009, Journal of hepatology.

[9]  T. Yamaoka,et al.  Intra‐hepatic arterial administration with miriplatin suspended in an oily lymphographic agent inhibits the growth of human hepatoma cells orthotopically implanted in nude rats , 2009, Cancer science.

[10]  M. Makuuchi,et al.  Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. , 2006, Gastroenterology.

[11]  T. Okusaka,et al.  Phase II Trial of Intra-Arterial Chemotherapy using a Novel Lipophilic Platinum Derivative (SM-11355) in Patients with Hepatocellular Carcinoma , 2004, Investigational New Drugs.

[12]  K. Tomita,et al.  Phase I clinical study of a novel lipophilic platinum complex (SM-11355) in patients with hepatocellular carcinoma refractory to cisplatin/lipiodol , 2003, British Journal of Cancer.

[13]  J. Bruix,et al.  Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival , 2003, Hepatology.

[14]  Pietro Andreone,et al.  Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials. , 2002, Radiology.

[15]  Ramon Planas,et al.  Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial , 2002, The Lancet.

[16]  John Wong,et al.  Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma , 2002, Hepatology.

[17]  H. Maeda,et al.  Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[18]  S. Fukushima,et al.  Antitumor effects of a novel lipophilic platinum complex (SM-11355) against a slowly-growing rat hepatic tumor after intra-hepatic arterial administration. , 2000, Biological & pharmaceutical bulletin.

[19]  M. Kusano,et al.  Prospective and randomized trial of lipiodol-transcatheter arterial chemoembolization for treatment of hepatocellular carcinoma: a comparison of epirubicin and doxorubicin (second cooperative study). The Cooperative Study Group for Liver Cancer Treatment of Japan. , 1997, Seminars in oncology.

[20]  K. Boudjema,et al.  Transcatheter oily chemoembolization for hepatocellular carcinoma. A 4‐year Study of 127 French Patients , 1994, Cancer.

[21]  M. Tatsuta,et al.  Treatment of hepatocellular carcinoma by transcatheter arterial embolization combined with intraarterial infusion of a mixture of cisplatin and ethiodized oil. , 1989, Gastroenterology.

[22]  S Sawada,et al.  Transcatheter oily chemoembolization of hepatocellular carcinoma. , 1989, Radiology.

[23]  Y. Liaw,et al.  Hepatic arterial embolization in patients with unresectable hepatocellular carcinoma--a randomized controlled trial. , 1988, Gastroenterology.

[24]  M. Maeda,et al.  Liposoluble platinum(II) complexes with antitumor activity. , 1986, Japanese journal of cancer research : Gann.